Astellas to restructure, close some research units
15 May 2013 | By Astellas
Astellas Pharma announces plans to reshape its research framework to further enhance the ability to generate innovative drugs...
List view / Grid view
News
FDA approves Tarceva (Erlotinib) tablets for specific type of lung cancer
15 May 2013 | By Astellas Pharma Inc.
The FDA also approved the cobas® EGFR Mutation Test, which was developed by Roche and validated in the pivotal EURTAC study...
Roche to present important new data reflecting broad cancer pipeline at ASCO
15 May 2013 | By Roche
Early stage data on investigational anti-PDL1 immunotherapy...
Sanofi and Regeneron announce patient enrollment in two Phase 3 trials with sarilumab in RA
15 May 2013 | By Sanofi
Comprehensive SARIL-RA development program to include 2,600 patients in four Phase 3 and one open-label extension trials...
Lonza launches 2013-2014 BioResearch Catalog
Diabetes prevention has become a key focus area for the drug development market.
Ranbaxy announces conclusion of previously disclosed investigation by U.S Department of Justice
13 May 2013 | By DAIICHI SANKYO COMPANY, LIMITED
"Today’s announcement marks the resolution of this past issue..."
U.S. FDA grants Priority Review to simeprevir for combination treatment of genotype 1 chronic hepatitis C
13 May 2013 | By Johnson & Johnson
The U.S. FDA has granted Priority Review to the NDA for simeprevir (TMC435)...
FDA accepts Biogen Idec’s BLA for first long-lasting factor VIII therapy for hemophilia A
13 May 2013 | By Biogen Idec
The U.S. FDA has accepted BLA for the marketing approval of ELOCTATE™...
BREO™ ELLIPTA™ gains US approval for the treatment of COPD
10 May 2013 | By GlaxoSmithKline
GlaxoSmithKline and Theravance announced that the US FDA has approved BREO™ ELLIPTA™...
Novartis drug Ilaris® approved by FDA
10 May 2013 | By Novartis
Novartis announced that the US Food and Drug Administration (FDA) has approved Ilaris® (canakinumab)...
GSK and Save the Children form unique partnership to save the lives of one million children
9 May 2013 | By GlaxoSmithKline
Working together to accelerate the availability of two children’s medicines...
Abbott announces CE Mark for test to aid doctors with diagnosing and monitoring diabetes
Abbott today announced CE Marking (Conformité Européenne) for the ARCHITECT clinical chemistry Hemoglobin A1c (HbA1c) test, which may aid physicians in diagnosing and monitoring diabetes as well as identifying patients at risk for developing diabetes.
Amgen and Zhejiang Beta Pharma announce planned joint venture in China
9 May 2013 | By Amgen
Goal is to bring Amgen's Vectibix® (panitumumab) to chinese patients...
GSK enters new commitment with the GAVI Alliance to supply cervical cancer vaccine for girls in the world’s poorest countries
9 May 2013 | By GlaxoSmithKline
GSK's new commitment to the GAVI Alliance...
Teva and Alexza announce Teva’s license to market ADASUVE® in the U.S.
8 May 2013 | By TEVA
Teva and Alexza have entered into an exclusive U.S. license and supply agreement...
